DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERD

Information source: Samsung Medical Center
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Gastroesophageal Reflux Disease

Intervention: Proton pump inhibitor (rabeprazole) (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: Samsung Medical Center

Official(s) and/or principal investigator(s):
Poong-Lyul Rhee, MD. Ph.D, Principal Investigator, Affiliation: Samsung Medical Center, Sungkyunkwan University School of Medicine

Overall contact:
Tae ggon Kim, Phone: +82-2-3410-2975, Email: tggo.kim@samsung.com

Summary

PPI test;empirical trial with high-dose proton-pump inhibitors (PPIs) has been shown to be a sensitive tool for diagnosing patients with GERD. However, this diagnostic strategy has not been well established in patients with extraesophageal manifestation of GERD. In this study, we aim to see the relevance of PPI test in diagnosing GERD in patients with extraesophageal symptoms.

Clinical Details

Official title: Clinical Usefulness of Proton Pump Inhibitor Test for Identifying Gastroesophageal Reflux Disease in Patients With Extraesophageal Symptoms

Study design: Diagnostic, Open Label, Parallel Assignment

Primary outcome: Symptom responders after PPI trials

Eligibility

Minimum age: 20 Years. Maximum age: 75 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patients with extraesophageal manifestation symptoms of GERD

Exclusion Criteria:

- laryngeal, pharyngeal, liver, lung, renal, or hematological disorders

- a history of gastrointestinal surgery, and a history of connective tissue disorders.

- patients with duodenal or gastric ulcers as well as other significant lesions, such

as gastric cancer, esophageal cancer, or subepithelial tumors more than 1 cm observed on the upper endoscopy

Locations and Contacts

Tae ggon Kim, Phone: +82-2-3410-2975, Email: tggo.kim@samsung.com

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Gangnam-gu 135-710, Korea, Republic of; Recruiting
Poong Lyul Rhee, M.D., Ph.D, Phone: +82-2-3410-3409, Email: plrhee@skku.edu
Poong-Lyul Rhee, M.D., Ph.D., Principal Investigator
Additional Information

Starting date: March 2006
Last updated: October 4, 2007

Page last updated: October 19, 2009

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009